The discovery of novel biomarkers might greatly contribute to improve clinical management and outcomes in uterine serous papillary carcinoma (USPC), a highly aggressive variant of endometrial cancer.
Citations
APA
Chicago
FWB
Santin, A. D., Diamandis, E. P., Bellone, S., Soosaipillai, A., Cané, S., Palmieri, M., Burnett, A., Roman, J. J., & Pecorelli, S. (2005). Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Clinical Cancer Research, 11(9), 3320-3325. https://doi.org/10.1158/1078-0432.CCR-04-2528 (Original work published 2005)